↓ Skip to main content

Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy

Overview of attention for article published in Cancer Cell International, June 2005
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)

Mentioned by

twitter
1 X user
patent
8 patents

Citations

dimensions_citation
196 Dimensions

Readers on

mendeley
160 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy
Published in
Cancer Cell International, June 2005
DOI 10.1186/1475-2867-5-18
Pubmed ID
Authors

Mario Boccadoro, Gareth Morgan, Jamie Cavenagh

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 160 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 2 1%
Korea, Republic of 1 <1%
Sweden 1 <1%
Australia 1 <1%
Spain 1 <1%
Denmark 1 <1%
Unknown 153 96%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 28 18%
Student > Bachelor 23 14%
Researcher 22 14%
Other 19 12%
Student > Master 17 11%
Other 26 16%
Unknown 25 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 38 24%
Medicine and Dentistry 38 24%
Biochemistry, Genetics and Molecular Biology 20 13%
Chemistry 13 8%
Pharmacology, Toxicology and Pharmaceutical Science 9 6%
Other 11 7%
Unknown 31 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 October 2022.
All research outputs
#3,052,148
of 23,466,057 outputs
Outputs from Cancer Cell International
#345
of 1,859 outputs
Outputs of similar age
#5,605
of 57,980 outputs
Outputs of similar age from Cancer Cell International
#1
of 2 outputs
Altmetric has tracked 23,466,057 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,859 research outputs from this source. They receive a mean Attention Score of 4.1. This one has done well, scoring higher than 81% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 57,980 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 2 others from the same source and published within six weeks on either side of this one. This one has scored higher than all of them